Taking Control Of Your Diabetes
Non-profit
Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, Taking Control of Your Diabetes educates and motivates people with diabetes to take a more active role in their condition. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesI Switched from the MiniMed 780G to the New MiniMed Flex: A Real-World Look at What Got Better, What Got Smaller, and What I Miss at 2:00 a.m.
Let’s Start with the Size The first thing you notice about the MiniMed Flex is the size. Actually, the first thing you notice is that you almost do not notice it at all. This thing is tiny. Really tiny. The MiniMed Flex is much, much smaller than the 780G, and the difference is immediately obvious. It slips into a pocket more easily, takes up less space, and is simply less noticeable on the body.
How I Reached 100% Time in Range Three Days in a Row!
DIY Loop App I’ve been using the Loop app for several years, and I love it. Loop is an automated insulin delivery app that connects insulin pumps with CGMs. It’s not FDA-approved, but thousands of people use it and have great success with it. One thing I like is that you can get a new operating system update once or twice a year, which would be impossible if you had to go through the FDA for each update.
Protected: Ask Dr. E: Do Oral GLP-1s Work As Well As Injections?
By TCOYD on July 23, 2026 / Ask Dr. E, GLP-1 RA, GLP-1/GIP, Medications This content is password-protected. To view it, please enter the password below. Password:
Protected: Your Heart, Your Kidneys, and Your Liver…the New Three Amigos of Diabetes!
By TCOYD on July 23, 2026 / Blood Pressure, Cholesterol, Diabetes Complications, Heart Disease, Inflammation, Insulin Resistance, Kidneys, Liver This content is password-protected. To view it, please enter the password below. Password:
Protected: GLP-1s for Type 1 Diabetes: The Benefits, Risks, and the Road to FDA Approval
This content is password-protected. To view it, please enter the password below.
Silent and Sneaky: How Liver Disease Hides From People With Diabetes
Diabetes and Liver Disease: Frequently Asked Questions ❤️🩹 Is there a cure for liver disease? While there isn’t a cure for liver disease currently, it can often be improved (and sometimes even reversed) in early stages with lifestyle changes. The liver has an amazing ability to heal itself when underlying causes like inflammation are addressed.
I Was Just Diagnosed with My Second Autoimmune Condition (Graves’ Disease) and Now My Thyroid Is as Big as My Prostate!
What Is Graves’ Disease? Graves’ disease is an autoimmune condition that causes hyperthyroidism, which means your thyroid gland becomes overactive (“hyper”) and starts producing too much thyroid hormone. Why does this happen? In all autoimmune diseases, the immune system attacks a specific target, but the consequence depends on what the immune attack does to that target. In type 1 diabetes, the immune system destroys the insulin-producing beta cells of the pancreas.
Ask Dr. E: How Do You Avoid the WAD (Wild Ass Guess) When Dosing Mealtime Insulin?
Rapid-Acting Insulin Afrezza Works Differently Than Injected Insulin The reason why Afrezza works so well for kids (especially unpredictable eaters) is due to the time course of action. Subcutaneous insulin typically starts working in 15-30 minutes, reaches its peak in 1-3 hours, and doesn’t get out of your system for 3-5 hours. Afrezza starts working in about 12 minutes, reaches its peak in about 45 minutes, and is out of your system in 1.5 to 3 hours.
Needle-Free Insulin for Kids Is Here! Afrezza Approval Is a Game-Changer!
Inhaled vs. Injected Insulin in Kids: What the Research Says The Afrezza FDA approval for kids and teens was based on results from the INHALE-1 study, which evaluated whether inhaled insulin could safely and effectively replace injected insulin at mealtimes for this age group. Half of the 230 participants in the 26-week study used Afrezza at mealtimes and for corrections, while the other half used injected rapid-acting insulin. Both groups used their long-acting injected basal insulin.
Who Is Most at Risk for DKA (and Who Thinks They Aren’t?)
Who Thinks They’re Not at Risk for DKA? The majority of people who don’t think they’re at risk for DKA are the ones who’ve never had it! It’s a natural assumption to think, “It hasn’t happened to me, so I must be doing something right”. But DKA can develop quickly (sometimes within hours) from an unexpected loss of insulin, an illness, or even certain medications.